When Is the Best Time for Your Wegovy Injection?

Wegovy is injected once every seven days — the same day weekly is the rule that matters most for consistent blood levels of semaglutide.
Time of day is flexible: morning and evening injections are both appropriate, and the NHS does not specify one over the other.
Nausea is most common shortly after each injection; some people choose evening dosing so any queasiness can pass during sleep.
If you miss your injection day by more than two days, follow the advice in your Patient Information Leaflet and contact your prescriber if you are unsure, never double-dose.

There is no single medically mandated time of day for your Wegovy injection — the guidance from the NHS is that the same chosen day each week matters far more than the specific hour. That said, many people find that building injection day into a predictable routine, whether morning or evening, genuinely improves consistency and helps manage short-term nausea. Wegovy is a once-weekly semaglutide injection licensed in the UK for weight management in adults, and as a prescription-only medicine it is started and titrated under the direction of a prescriber. The timing details below are educational; your prescriber and the Patient Information Leaflet supplied with your treatment are your definitive guides for anything specific to your own situation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A practical step-by-step to building your Wegovy injection routine

Step 1, Pick a fixed weekly day that you can protect

The most clinically important timing decision is not the hour but the day. Semaglutide's half-life of roughly one week means it accumulates steadily in your system when injected on a consistent schedule; shifting your injection day around disrupts that steady state and can make side effects less predictable. Choose a day you can reliably commit to, many people anchor it to something fixed, like the start of a working week or a weekend morning when they are not rushing. Settling on a consistent injection day is the single change that has the biggest impact on adherence, according to the NHS guidance on weight-management injections.

Write the day into your phone calendar with a reminder. If life forces a rare shift, NHS guidance says you can take the injection up to two days either side of your planned day, but this is a safety net, not a habit. Check the Patient Information Leaflet for exact missed-dose instructions, because the rules change depending on how close the next dose is.

Step 2, Choose a time of day that fits your life, then keep it

A question our prescribers hear most weeks is whether morning or evening is better. The honest clinical answer: neither is superior in terms of how well semaglutide works. What is true is that nausea tends to arrive in the first few hours after injection and usually peaks around the two-to-four-hour mark, then fades. Knowing that, some people sensibly prefer an evening dose so that if they feel queasy they can simply sleep through the worst of it. Others find morning works better because they want to be alert when they first inject.

The time-of-day question ultimately comes down to your routine and how you respond to the medicine. If nausea has been a real problem at your current titration step, raise it with your prescriber, dose timing is one tool in managing it, but adjusting how and when you eat around injection day is often equally useful. The NHS medicines page for semaglutide has straightforward guidance on what to expect.

Step 3, Set up your space before you inject

Consistency of timing is easier when the physical routine feels automatic. Before each injection: take the pen from the fridge and allow it to sit at room temperature for around 30 minutes, cold medicine can sting more on injection. Select and clean the site (abdomen, thigh or upper arm) with an alcohol swab and let it dry. Rotate your injection site each week to reduce localised reactions; the NHS recommends not using the exact same spot twice in a row.

After the injection, dispose of the needle safely, a dedicated sharps container is the right way to do it, not a household bin. The pen itself is pre-filled and pre-set; you do not adjust the dose yourself. Storage matters too: unused pens go straight back into the fridge at 2–8°C. For the exact temperature window and how long a pen may stay out of refrigeration, the Patient Information Leaflet is the authority, the figure can vary and it changes nothing to guess.

Step 4, Track your pattern and tell your prescriber what you notice

Once you have a day and time, keep a simple log for the first few weeks: how you felt in the hours after injection, whether appetite changed noticeably by day three or four, and any symptoms worth flagging. This record is genuinely useful at your next clinical review. If nausea, diarrhoea or fatigue are consistently disruptive, that is worth raising rather than pushing through quietly, your prescriber can help assess whether it's timing, diet around injection day, or the current dose level that needs adjusting.

Wegovy is titrated in steps, starting at 0.25mg and escalating roughly every four weeks under prescriber direction, so side effects often shift at each new level. Understanding that pattern makes it easier to tell the difference between transient adjustment and something that needs attention. If you want to read more about the injection technique itself, or are curious about how Wegovy's results compare across different scenarios, our Wegovy overview covers both. And if you are weighing up the cost of ongoing treatment, the Wegovy pricing page sets out what private treatment typically involves, including what an all-in price should cover.

One thing worth saying plainly: if you ever experience severe, persistent stomach pain that moves towards your back, seek medical help promptly rather than waiting for your next routine check-in. The MHRA highlighted acute pancreatitis as an infrequent but serious side effect of GLP-1 medicines in a Drug Safety Update published in January 2026. It is rare, but it is the kind of symptom to act on, not monitor.

If you are still working out whether Wegovy is right for your situation, or you are transferring from another provider and want clinical review, check your eligibility through a free consultation with one of our GPhC-registered prescribers.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions